A detailed history of Banco De Sabadell, S.A transactions in Merck & Co., Inc. stock. As of the latest transaction made, Banco De Sabadell, S.A holds 10,984 shares of MRK stock, worth $1.09 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares
10,984
Holding current value
$1.09 Million
% of portfolio
0.93%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$111.15 - $128.97 $1.22 Million - $1.42 Million
10,984 New
10,984 $1.25 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $57,824 - $72,432
-800 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $2.86 Million - $3.16 Million
-40,693 Reduced 98.07%
800 $62,000
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $2.95 Million - $3.48 Million
-42,848 Reduced 50.8%
41,493 $3.21 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $3.02 Million - $3.35 Million
42,030 Added 99.34%
84,341 $6.85 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $2.79 Million - $3.17 Million
38,162 Added 919.79%
42,311 $3.49 Million
Q2 2020

Aug 07, 2020

SELL
$70.42 - $80.13 $2.89 Million - $3.29 Million
-41,057 Reduced 90.82%
4,149 $318,000
Q1 2020

May 14, 2020

SELL
$63.36 - $87.82 $809,614 - $1.12 Million
-12,778 Reduced 22.04%
45,206 $3.45 Million
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $2.68 Million - $3.03 Million
34,593 Added 147.89%
57,984 $5.28 Million
Q3 2019

Nov 15, 2019

SELL
$76.08 - $82.93 $1.6 Million - $1.75 Million
-21,096 Reduced 47.42%
23,391 $1.96 Million
Q2 2019

Aug 13, 2019

BUY
$69.84 - $81.59 $3.01 Million - $3.52 Million
43,087 Added 3077.64%
44,487 $3.73 Million
Q3 2018

Nov 16, 2018

BUY
$57.69 - $67.84 $80,766 - $94,976
1,400 New
1,400 $99,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Banco De Sabadell, S.A Portfolio

Follow Banco De Sabadell, S.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.